Biomarkers in Alzheimer's Disease provides a comprehensive overview of all modalities of Alzheimer's disease biomarkers, including neuroimaging, cerebrospinal fluid, genomic, and peripheral systems. Each chapter integrates molecular/cellular abnormality due to Alzheimer's disease and technological advancement of biomarkers techniques.
The book is ideal for clinical neuroscience and molecular/cellular neuroscience researchers, psychiatrists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer's disease, and for differential diagnosis of Alzheimer's disease with other non-Alzheimer's dementia.
- Presents a comprehensive overview detailing all modalities of Alzheimer's disease biomarkers
- Written for neuroscience researchers and clinicians studying or treating patients with Alzheimer's Disease
- Integrates, in each chapter, the molecular/cellular abnormality due to Alzheimer's disease and the technological advancement of biomarkers techniques
Chapter 1: Introduction to Alzheimer's Disease Biomarkers
Chapter 2: Clinical Diagnosis of Alzheimer's Disease
Chapter 3: Neuroimaging Biomarkers in Alzheimer's Disease
Chapter 4: Genetic Biomarkers in Alzheimer's Disease
Chapter 5: Alzheimer's Disease Cerebrospinal Fluid (CSF) Biomarkers
Chapter 6: Peripheral Fluid-Based Biomarkers of Alzheimer's Disease
Chapter 7: Cell-Based Alzheimer's Disease Biomarkers
Dr. Khan is an Associate Professor at the Blanchette Rockefeller Neurosciences Institute (BRNI). BRNI is operated in alliance with West Virginia University in Morgantown, USA. Dr. Khan has more than a decade of research experience in the Alzheimer's disease research area. He is an Associate Editor for Journal of Alzheimer's Disease and is a regular reviewer for many journals including: European Journal of Pharmaceutical Sciences, Bioorganic & Medicinal Chemistry, CNS & Neurological Disorders-Drug Targets, Neuropeptides, Journal of Biomolecular Structure & Dynamics, Stem Cell Research & Therapy.